Synergistic activity of colistin and ceftazidime against multiantibiotic-resistant Pseudomonas aeruginosa in an in vitro pharmacodynamic model

Antimicrobial Agents and Chemotherapy

Volumn 47, Issue 3, 2003, Pages 905-909

  Gunderson, Brent W ^a   Ibrahim, Khalid H ^a   Hovde, Laurie B ^a   Fromm, Timothy L ^a   Reed, Michael D ^b   Rotschafer, John C ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; IMIPENEM; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN; TOBRAMYCIN;

ACINETOBACTER; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; COLONY FORMING UNIT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG HALF LIFE; DRUG POTENTIATION; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

ANTI-BACTERIAL AGENTS; AREA UNDER CURVE; CEFTAZIDIME; CEPHALOSPORINS; COLISTIN; COLONY COUNT, MICROBIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DRUG SYNERGISM; MICROBIAL SENSITIVITY TESTS; MODELS, BIOLOGICAL; PSEUDOMONAS AERUGINOSA;

EID: 0037416978     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.47.3.905-909.2003     Document Type: Article

References (17)

1. Barnett, M., S. R. M. Bushby, and S. Wilkinson. 1964. Sodium sulphomethyl derivatives of polymyxins. Br. J. Pharmacol. 23:552-574.
2. Beveridge, E. G., and A. J. Martin. 1967. Sodium sulphomethyl derivatives of polymyxins. Br. J. Pharmacol. 29:125-135.
3. Bosso, J. A., C. A. Liptak, D. K. Seilheimer, and G. M. Harrison. 1991. Toxicity of colistin in cystic fibrosis patients. DICP 25:1168-1170.
4. Catchpole, C. R., J. M. Andrews, N. Brenwald, and R. Wise. 1997. A reassessment of the in-vitro activity of colistin sulphomethate sodium. J. Antimicrob. Chemother. 39:255-260.
5. Conway, S. P., M. N. Pond, A. Watson, C. Etherington, H. L. Robey, and M. H. Goldman. 1997. Intravenous colistin sulphomethate in acute respiratory exacerbations in adult patients with cystic fibrosis. Thorax 52:987-993.
6. Craig, W. A. 1998. Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clin. Infect. Dis. 26:1-10.
7. Craig, W. A., and C. M. Kunin. 1976. Significance of serum protein and tissue binding of antimicrobial agents. Annu. Rev. Med. 27:287-300.
8. Eickhoff, T. C., and M. Finland. 1965. Polymyxin B and colistin: in vitro activity against Pseudomonas aeruginosa. Am. J. Med. Sci. 249:172-174.
9. Evans, M. E., D. J. Feola, and R. P. Rapp. 1999. Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant gram-negative bacteria. Ann. Pharmacother. 33:960-967.
10. Froman, J., L. Gross, and S. Curatola. 1970. Serum and urine levels following parenteral administration of sodium colistimethate to normal individuals. J. Urol. 103:210-214.
11. Kucers, A., and N. M. Bennett. 1987. The use of antibiotics: a comprehensive review with clinical emphasis, 4th ed., p. 899-913. Lippincott, Philadelphia, Pa.
12. Levin, A. S., A. A. Barone, J. Penco, M. V. Santos, I. S. Marinho, E. A. Arruda, E. I. Manrique, and S. F. Costa. 1999. Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii. Clin. Infect. Dis. 28:1008-1011.
13. Li, J., J. Turnidge, R. Milne, R. L. Nation, and K. Coulthard. 2001. In vitro pharmacodynamic properties of colistin and colistin methanesulfonate against Pseudomonas aeruginosa isolates from patients with cystic fibrosis. Antimicrob. Agents Chemother. 45:781-785.
14. Li, R. C., D. E. Nix, and J. J. Schentag. 1994. Interaction between ciprofloxacin and metal cations: its influence on physicochemical characteristics and antibacterial activity. Pharm. Res. 11:917-920.
15. Reed, M. D., R. C. Stern, M. A. O'Riordan, and J. L. Blumer. 2001. The pharmacokinetics of colistin in patients with cystic fibrosis. J. Clin. Pharmacol. 41:645-654.
16. Verpooten, G. A., R. A. Giuliano, L. Verbist, G. Eestermans, and M. E. De Broe. 1989. Once-daily dosing decreases renal accumulation of gentamicin and netilmicin. Clin. Pharmacol. Ther. 45:22-27.
17. Zabinski, R. A., K. Vance-Bryan, A. J. Krinke, K. J. Walker, J. A. Moody, and J. C. Rotschafer. 1993. Evaluation of activity of temafloxacin against Bacteroides fragilis by an in vitro pharmacodynamic system. Antimicrob. Agents Chemother. 37:2454-2458.